换一批
换一批Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1).
第一作者：
Désirée,van der Heijde
第一单位：
From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA. mail@dvanderheijde.nl.;D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company. mail@dvanderheijde.nl.;D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington. mail@dvanderheijde.nl.
作者：
主题词
成年人(Adult);抗风湿药(Antirheumatic Agents);关节炎, 牛皮癣(Arthritis, Psoriatic);背痛(Back Pain);皮肤科用药(Dermatologic Agents);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);白细胞介素17(Interleukin-17);男(雄)性(Male);中年人(Middle Aged);鼻咽炎(Nasopharyngitis);生活质量(Quality of Life);呼吸道感染(Respiratory Tract Infections);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)
DOI
10.3899/jrheum.170429
PMID
29247148
发布时间
2022-03-21
- 浏览15
The Journal of rheumatology
367-377页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
